TR200401815T4 - Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı. - Google Patents

Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı.

Info

Publication number
TR200401815T4
TR200401815T4 TR2004/01815T TR200401815T TR200401815T4 TR 200401815 T4 TR200401815 T4 TR 200401815T4 TR 2004/01815 T TR2004/01815 T TR 2004/01815T TR 200401815 T TR200401815 T TR 200401815T TR 200401815 T4 TR200401815 T4 TR 200401815T4
Authority
TR
Turkey
Prior art keywords
domestic animals
pyrimidine
endothelin antagonists
endothelin
antagonists
Prior art date
Application number
TR2004/01815T
Other languages
English (en)
Inventor
Banks J.Bernard
Foster P.Adrian
Gibson P.Stephen
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of TR200401815T4 publication Critical patent/TR200401815T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)

Abstract

Ikame maddelerinin burada tarif edilen degerlere sahip oldugu formül I'in bilesikleri, evcil hayvanlarda özellikle köpekler, kendiler ve atlarda endotelin'in aracilik ettigi bozukluklarin iyilestirilmesinde faydalidir.
TR2004/01815T 2000-02-11 2001-02-06 Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı. TR200401815T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0003234.2A GB0003234D0 (en) 2000-02-11 2000-02-11 Method of treatment
PCT/IB2001/000142 WO2001058882A1 (en) 2000-02-11 2001-02-06 Use of pyrimidine endothelin antagonists in companion animals

Publications (1)

Publication Number Publication Date
TR200401815T4 true TR200401815T4 (tr) 2004-08-23

Family

ID=9885465

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01815T TR200401815T4 (tr) 2000-02-11 2001-02-06 Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı.

Country Status (17)

Country Link
EP (1) EP1254120B1 (tr)
JP (1) JP2003528050A (tr)
KR (1) KR20020075791A (tr)
AT (1) ATE271042T1 (tr)
AU (1) AU3043601A (tr)
CA (1) CA2398007A1 (tr)
DE (1) DE60104283T2 (tr)
DK (1) DK1254120T3 (tr)
ES (1) ES2222975T3 (tr)
GB (1) GB0003234D0 (tr)
HU (1) HUP0204370A3 (tr)
IL (1) IL150488A0 (tr)
NZ (1) NZ519002A (tr)
PT (1) PT1254120E (tr)
TR (1) TR200401815T4 (tr)
WO (1) WO2001058882A1 (tr)
ZA (1) ZA200206343B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
AU2006236345B2 (en) * 2005-04-19 2011-03-31 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
US8778617B2 (en) * 2010-02-25 2014-07-15 Hoffmann-La Roche Inc. Method for determining the binding constant of high affinity compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3087968B2 (ja) * 1995-12-20 2000-09-18 山之内製薬株式会社 アリールエテンスルホンアミド誘導体及びその医薬組成物
WO1998057938A1 (en) * 1997-06-19 1998-12-23 Yamanouchi Pharmaceutical Co., Ltd. Substituted lower alkanesulfonamide derivatives and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
EP1254120B1 (en) 2004-07-14
HUP0204370A2 (en) 2003-05-28
GB0003234D0 (en) 2000-04-05
DE60104283T2 (de) 2004-11-18
AU3043601A (en) 2001-08-20
KR20020075791A (ko) 2002-10-05
ZA200206343B (en) 2003-08-08
IL150488A0 (en) 2002-12-01
HUP0204370A3 (en) 2003-07-28
ATE271042T1 (de) 2004-07-15
ES2222975T3 (es) 2005-02-16
CA2398007A1 (en) 2001-08-16
JP2003528050A (ja) 2003-09-24
EP1254120A1 (en) 2002-11-06
DK1254120T3 (da) 2004-10-04
DE60104283D1 (de) 2004-08-19
WO2001058882A1 (en) 2001-08-16
PT1254120E (pt) 2004-10-29
NZ519002A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
DK1257175T3 (da) Brug af syrestabile Subtilisin Proteaser i dyrefoder.
EA200100731A1 (ru) Фенилфенантридины с ингибирующей фдэ-4 активностью
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
YU72002A (sh) Benzoilpirazoli i njihova primena u ulozi herbicida
DK1585737T3 (da) Uraciler med herbicid virkning
WO2001046165A3 (en) N-heteroaryl-amides and their use as parasiticides
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
CO5160266A1 (es) Nuevos agentes antibacterianos de isoxazolinona
EA200301100A1 (ru) Новые фталазиноны
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
ATE418552T1 (de) Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
MXPA03011630A (es) Compuestos de amenoacetonitrilo para el control de endoparasitos.
DE60202669D1 (de) 6-phenylbenzonaphthyidine
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
TR200401815T4 (tr) Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı.
DE60322110D1 (de) Substituierte 4-(4-piperidin-yl-piperazin-1-yl)-azntagonisten
BR0011330A (pt) 2-aril-1,2,4-triazina-3,5-di(ti)onas substituìdas
DK1051404T3 (da) Substituerede phenyluraciler med herbicid virkning
ATE285759T1 (de) Neuropeptid y antagonisten
MXPA04004020A (es) Tien-3-ilsulfonilamino(tio)carbonil-triazolin(tio)onas substituidas.
DE60120398D1 (de) Imidazopyridin-8-one
ATE319695T1 (de) N,n'-disubstituierte piperazin-verbindungen und ihre verwendung als schmerzmittel